Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines.
Hussein IbrahimXiaoxuan LiuSamantha Cruz RiveraDavid MoherAn-Wen ChanMatthew R SydesMelanie J CalvertAlastair Keith DennistonPublished in: Trials (2021)
The SPIRIT-AI and CONSORT-AI guidelines provide the first international standards for clinical trials of AI systems. The guidelines are designed to ensure complete and transparent reporting of clinical trial protocols and reports involving AI interventions and have the potential to improve the quality of these clinical trials through improvements in their design and delivery. Their use will help to efficiently identify the safest and most effective AI interventions and commission them with confidence for the benefit of patients and the public.
Keyphrases
- artificial intelligence
- clinical trial
- machine learning
- big data
- deep learning
- phase ii
- clinical practice
- physical activity
- end stage renal disease
- adverse drug
- healthcare
- chronic kidney disease
- randomized controlled trial
- newly diagnosed
- phase iii
- open label
- double blind
- study protocol
- peritoneal dialysis
- quality improvement